Artwork

Content provided by TLC Sessions. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by TLC Sessions or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Episode 64: Michael Peluso, M.D. – Viral reservoirs and Monoclonal Antibody treatment trial

1:02:09
 
Share
 

Manage episode 379245698 series 2949473
Content provided by TLC Sessions. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by TLC Sessions or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

Michael Peluso M.D., an HIV and infectious disease specialist at UCSF, has been studying Long Covid patients since April 2020 (LIINC Study). This, along with his history of working with HIV and other viruses, has given him the knowledge and methods to make some break-throughs into Long Covid pathogenesis, effects and, potentially, treatments. He, along with his team, has established that Long Covid causes T-cell and immune dysregulation and he has used multimodal molecular imaging to reveal that viral RNA reservoirs are persistent in Long Covid patients. With the aim of clearing this viral debris, Peluso is now leading a clinical trial using a monoclonal antibody infusion.
Living with Long Covid? How was your week?
Website - https://www.tlcsessions.net/
Twitter - @SessionsTlc https://twitter.com/sessionstlc
Insta - @tlcsessions https://www.instagram.com/tlcsessions

  continue reading

82 episodes

Artwork
iconShare
 
Manage episode 379245698 series 2949473
Content provided by TLC Sessions. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by TLC Sessions or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

Michael Peluso M.D., an HIV and infectious disease specialist at UCSF, has been studying Long Covid patients since April 2020 (LIINC Study). This, along with his history of working with HIV and other viruses, has given him the knowledge and methods to make some break-throughs into Long Covid pathogenesis, effects and, potentially, treatments. He, along with his team, has established that Long Covid causes T-cell and immune dysregulation and he has used multimodal molecular imaging to reveal that viral RNA reservoirs are persistent in Long Covid patients. With the aim of clearing this viral debris, Peluso is now leading a clinical trial using a monoclonal antibody infusion.
Living with Long Covid? How was your week?
Website - https://www.tlcsessions.net/
Twitter - @SessionsTlc https://twitter.com/sessionstlc
Insta - @tlcsessions https://www.instagram.com/tlcsessions

  continue reading

82 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide